The inhibin/activin family and ovarian cancer
- 31 August 1996
- journal article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 7 (6) , 197-202
- https://doi.org/10.1016/1043-2760(96)00107-5
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumoursClinical Endocrinology, 1996
- Quantification of inhibin pro-alpha C-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assayJournal of Clinical Endocrinology & Metabolism, 1995
- Inhibin as a marker for ovarian cancerBritish Journal of Cancer, 1995
- Inhibin and Activin Are Demonstrable by Immunohistochemistry in Ovarian Tumor TissueGynecologic Oncology, 1995
- Detection of dimeric inhibin throughout the human menstrual cycle by two‐site enzyme immunoassayClinical Endocrinology, 1994
- Clinical review 46: Clinical utility of inhibin measurementsJournal of Clinical Endocrinology & Metabolism, 1993
- Competitive protein binding assay for activin AEDF using follistatin determination of activin levels in human plasmaBiochemical and Biophysical Research Communications, 1992
- InhibinReproductive Medicine Review, 1992
- Evidence for an Autocrine Role of Activin B within Rat Anterior Pituitary CulturesEndocrinology, 1991
- Adenylate cyclase in human ovarian cancers: Sensitivity to gonadotropins and nonhormonal activatorsAmerican Journal of Obstetrics and Gynecology, 1985